Could a simple test spot diabetes before it starts?
NCT ID NCT05505669
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is looking for biological markers (biomarkers) in blood, saliva, and urine that signal damage to insulin-producing beta cells in the pancreas. Researchers will compare samples from people with type 1 diabetes, type 2 diabetes, prediabetes, and healthy volunteers. The goal is to better understand how diabetes develops and find ways to diagnose it earlier.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors detect diabetes earlier and develop new treatments that protect or repair insulin-producing cells.
- What could go wrong
- This is an observational study, not a treatment trial. It may not find clear biomarkers, and any discoveries would need years of further research before helping patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- A new rice could tame blood sugar spikes in prediabetes
- Blood test could predict who faces rapid kidney decline in diabetes
- Can an app and cash rewards tame type 1 diabetes in young adults?
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes